Private · Company · Aksjeselskap
Arxx Therapeutics AS
815 295 242 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
↳ Brreg · companies
MoneyNOK
Revenue
kr 4.75M
Operating result
−kr 196.9M
Net result
−kr 198.1M
Total assets
kr 215.8M
Equity
kr 13.6M
FY2025 kr 4.75M vs FY2024 kr 5M · -5% revenue
Regnskapsregisteret · company_financials · FY2025 (company)
Group financialsNOK
- Revenue
- Net profit
| FY24 | FY25 | |
|---|---|---|
| Revenue | 5M | 4.75M |
| Net profit | -67M | -198.1M |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY24FY25TREND
Revenue5M5M
Operating result-67M-197M
Net result-67M-198M
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITAudited by BJØRGVIN REVISJON AS.
BALANCEEquity kr 13.6M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose